Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Carroll

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
Cancer Genetics|April 29, 2021
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AMLRobyn T Sussman, Bryan Manning, Daniel Ackerman, et al.
Drugs in R&D|September 24, 2024
Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid LeukemiaMathieu Quesnel-Vallières, David C Schultz, Alena Orlenko, et al.
Blood Advances|May 25, 2019
Gilteritinib induces differentiation in relapsed and refractory <i>FLT3</i>-mutated acute myeloid leukemiaChristine M McMahon, Jonathan Canaani, Bryan Rea, et al.
Blood|November 7, 2007
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disordersElizabeth O Hexner, Cynthia Serdikoff, Mahfuza Jan, et al.
Experimental Hematology|June 28, 2011
Diagnostic microRNAs in myelodysplastic syndromeBegum Erdogan, Crystal Facey, Julianne Qualtieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2016
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell TransplantationMarlise R Luskin, Martin Carroll, David Lieberman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cellsSteven J Bensinger, Patrick T Walsh, Jidong Zhang, et al.
American Journal of Hematology|November 3, 2016
Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AMLCourtney D Dinardo, Marlise R Luskin, Martin Carroll, et al.
Blood|March 6, 2014
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cellsSaar Gill, Sarah K Tasian, Marco Ruella, et al.
Leukemia & Lymphoma|June 7, 2006
A predictive model for the detection of tumor lysis syndrome during AML induction therapyAnthony R Mato, Brett E Riccio, Li Qin, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
Cancer Genetics|April 29, 2021
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AMLRobyn T Sussman, Bryan Manning, Daniel Ackerman, et al.
Drugs in R&D|September 24, 2024
Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid LeukemiaMathieu Quesnel-Vallières, David C Schultz, Alena Orlenko, et al.
Blood Advances|May 25, 2019
Gilteritinib induces differentiation in relapsed and refractory <i>FLT3</i>-mutated acute myeloid leukemiaChristine M McMahon, Jonathan Canaani, Bryan Rea, et al.
Blood|November 7, 2007
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disordersElizabeth O Hexner, Cynthia Serdikoff, Mahfuza Jan, et al.
Experimental Hematology|June 28, 2011
Diagnostic microRNAs in myelodysplastic syndromeBegum Erdogan, Crystal Facey, Julianne Qualtieri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2016
Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell TransplantationMarlise R Luskin, Martin Carroll, David Lieberman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cellsSteven J Bensinger, Patrick T Walsh, Jidong Zhang, et al.
American Journal of Hematology|November 3, 2016
Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AMLCourtney D Dinardo, Marlise R Luskin, Martin Carroll, et al.
Blood|March 6, 2014
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cellsSaar Gill, Sarah K Tasian, Marco Ruella, et al.
Leukemia & Lymphoma|June 7, 2006
A predictive model for the detection of tumor lysis syndrome during AML induction therapyAnthony R Mato, Brett E Riccio, Li Qin, et al.
Pageof 13